Hikal (HIKAL)
FAST GROWERFairStock Score: 26/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹187.05 |
| Market Cap | ₹2,425.08 Cr |
| P/E Ratio | 97 |
| ROCE | 9.85% |
| ROE | -1.08% |
| Dividend Yield | 0.71% |
| Profit Growth | 86.63% |
| Debt/Equity | — |
| Sales Growth | 10.41% |
| Promoter Holding | 68.85% |
| 52-Week Range | ₹146.25 — ₹386.25 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹98.44 |
Hikal trades with a P/E ratio of 97, ROCE of 9.85%, ROE of -1.08%, profit growth of 86.63%. The FairStock Score of 26/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer